Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Goodyer, I. M.
Herbert, J.
Altham, P. M. E.
Pearson, J.
Secher, S. M.
and
Shiers, H. M.
1996.
Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation.
Psychological Medicine,
Vol. 26,
Issue. 2,
p.
245.
Brown, George W.
1996.
Genetics of depression: a social science perspective.
International Review of Psychiatry,
Vol. 8,
Issue. 4,
p.
387.
Fombonne, Eric
1997.
Depression in children and adolescents.
Current Opinion in Psychiatry,
Vol. 10,
Issue. 4,
p.
275.
1998.
Comorbid OCD, higher score on the MFQ, and older age at presentation predicted persistence of major depression in children and adolescents.
Evidence Based Mental Health,
Vol. 1,
Issue. 1,
p.
24.
Christiansen, K. H.
1998.
Behavioral correlates of dehydroepiandrosterone and dehydroepiandrosterone sulfate.
The Aging Male,
Vol. 1,
Issue. 2,
p.
103.
Kimonides, V. G.
Khatibi, N. H.
Svendsen, C. N.
Sofroniew, M. V.
and
Herbert, J.
1998.
Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity.
Proceedings of the National Academy of Sciences,
Vol. 95,
Issue. 4,
p.
1852.
Herbert, J
1998.
Neurosteroids, brain damage, and mental illness.
Experimental Gerontology,
Vol. 33,
Issue. 7-8,
p.
713.
Wolkowitz, Owen M.
and
Reus, Victor I.
1999.
Treatment of Depression With Antiglucocorticoid Drugs.
Psychosomatic Medicine,
Vol. 61,
Issue. 5,
p.
698.
Kroboth, Patricia D.
Salek, Firoozeh S.
Pittenger, Amy L.
Fabian, Tanya J.
and
Frye, Reginald F.
1999.
DHEA and DHEA‐S: A Review.
The Journal of Clinical Pharmacology,
Vol. 39,
Issue. 4,
p.
327.
Kimonides, V.G.
Spillantini, M.G.
Sofroniew, M.V.
Fawcett, J.W.
and
Herbert, J.
1999.
Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures.
Neuroscience,
Vol. 89,
Issue. 2,
p.
429.
Dubrovsky, B
2000.
The specificity of stress responses to different nocuous stimuli: neurosteroids and depression.
Brain Research Bulletin,
Vol. 51,
Issue. 6,
p.
443.
Harris, T. O.
Borsanyi, S.
Messari, S.
Stanford, K.
Cleary, S. E.
Shiers, H. M.
Brown, G. W.
and
Herbert, J.
2000.
Morning cortisol as a risk factor for subsequent major depressive disorder in adult women.
British Journal of Psychiatry,
Vol. 177,
Issue. 6,
p.
505.
Compagnone, Nathalie A.
and
Mellon, Synthia H.
2000.
Neurosteroids: Biosynthesis and Function of These Novel Neuromodulators.
Frontiers in Neuroendocrinology,
Vol. 21,
Issue. 1,
p.
1.
Michael, Albert
and
O'Keane, Veronica
2000.
Sexual dysfunction in depression.
Human Psychopharmacology: Clinical and Experimental,
Vol. 15,
Issue. 5,
p.
337.
Michael, Albert
Jenaway, Alison
Paykel, Eugene S
and
Herbert, Joe
2000.
Altered salivary dehydroepiandrosterone levels in major depression in adults.
Biological Psychiatry,
Vol. 48,
Issue. 10,
p.
989.
Kaminska, M
Harris, J
Gijsbers, K
and
Dubrovsky, B
2000.
Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. implications for depression.
Brain Research Bulletin,
Vol. 52,
Issue. 3,
p.
229.
Wolkowitz, Owen M.
and
Reus, Victor I.
2000.
Dehydroepiandrosterone (DHEA).
Rief, Winfried
and
Auer, Claudia
2000.
Cortisol and somatization.
Biological Psychology,
Vol. 53,
Issue. 1,
p.
13.
Goodyer, I. M.
Park, R. J.
Netherton, C. M.
and
Herbert, J.
2001.
Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology.
British Journal of Psychiatry,
Vol. 179,
Issue. 3,
p.
243.
Wolkowitz, Owen M.
Epel, Elissa S.
and
Reus, Victor I.
2001.
Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications.
The World Journal of Biological Psychiatry,
Vol. 2,
Issue. 3,
p.
115.